Vident Advisory’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.4M | Buy |
52,067
+49,039
| +1,620% | +$10.7M | 0.13% | 148 |
|
|
2025
Q1 | $678K | Buy |
3,028
+643
| +27% | +$144K | 0.01% | 878 |
|
|
2024
Q4 | $781K | Buy |
2,385
+484
| +25% | +$159K | 0.01% | 746 |
|
|
2024
Q3 | $571K | Sell |
1,901
-9,881
| -84% | -$2.97M | 0.01% | 858 |
|
|
2024
Q2 | $3.88M | Buy |
11,782
+2,271
| +24% | +$748K | 0.11% | 189 |
|
|
2024
Q1 | $3.76M | Buy |
9,511
+7,835
| +467% | +$3.1M | 0.08% | 252 |
|
|
2023
Q4 | $590K | Buy |
1,676
+12
| +0.7% | +$4.23K | 0.01% | 716 |
|
|
2023
Q3 | $624K | Buy |
+1,664
| New | +$624K | 0.02% | 640 |
|